Labiotech.eu

abbvie ablynx rheumatoid arthritis nanobody

News and Trends 11 Jul 2016

Nanobody Phase II Results for Arthritis: Good but not good enough?

Ablynx has shown that its candidate for Rheumatoid arthritis could work as a monotherapy, but whether they can convince AbbVie to stick to the previous $840M deal is still unclear. Ghent-based Ablynx has hooked several big Pharmas with its Nanobody platform, based on the shorter monoclonal antibodies of llamas. One of these is AbbVie (France), which is […]

July 11, 2016 - 3 minutesmins - By Denise Neves Gameiro

News and Trends 11 Jul 2016

How to build a Successful Biotech company in Europe with Joern Aldag

Joern Aldag is one of the impressive Biotech leaders in Europe. Hearing him at our Refresh conference made me think of a new type of article we could publish: a detailed summary of the lessons learned from such a very rich career. Here’s the first of such a piece. Aldag was just appointed CEO of […]

July 11, 2016 - 6 minutesmins - By Philip Hemme

charles darwin bristol graffiti origin species bioart simon park e1467992003422

News and Trends 9 Jul 2016

Bio-printing Clothes and Darwin’s book ‘On the Origin of Species’ with Bacteria

Simon Park is a professor at the University of Surrey in the UK who created the first book to be ‘printed’ with living bacteria, whereas Suzanne Lee is a New York based designer who uses the same species of bacteria in her clothing designs. This is probably one of the most unusual tributes to Charles Darwin, the English naturalist and geologist […]

July 9, 2016 - 4 minutesmins - By Joachim Eeckhout

News and Trends 8 Jul 2016

Copenhagen-based Pcovery is looking to fight invasive Fungal Infections

After another visit to the United Kingdom, we ‘Brexit’ towards other geographies! We’re crossing the English Channel back to the continent and go further up to Denmark. This week, in Copenhagen, we’re visiting Pcovery, our Biotech of the Week. City: Copenhagen (Denmark) Founded: 2009 Employees: 6 Financial Data: €7.5M Total Raised (as of 12/2015) CEO: Casper Tind Hansen […]

July 8, 2016 - 2 minutesmins - By Joachim Eeckhout

News and Trends 8 Jul 2016

French Startup raised €4M for Gene Therapy to fix specific Types of Blindness

Horama is developing gene therapies for several hereditary retinal dystrophies. It has now raised €4M in its Series A round, which will speed up development of two candidates. Eye disorders are a popular indication for gene therapies, especially after the first gene therapy approvals – uniQure’s Glybera and GSK’s Strimvelis. Some other players in ophthalmologic […]

July 8, 2016 - 2 minutesmins - By Denise Neves Gameiro

zika sanofi niaid army us vaccine biotech

News and Trends 7 Jul 2016

Sanofi and the US Army team up for a Zika Vaccine, but why isn’t everyone else?

Together with the US Walter Reed Army Institute of Research (WRAIR), the French infectious disease specialist, Sanofi Pasteur, hopes to speed up their promising new Zika virus vaccine. With the concerns over the borderline epidemic of the Zika virus, with its mysterious origins and not fully understood pathophysiology, the Biotech and pharmaceutical industries have united globally […]

July 7, 2016 - 4 minutesmins - By Dani Bancroft

News and Trends 7 Jul 2016

How to Integrate a Digital Notebook into your Lab?

Software solutions, such as digital notebooks, can help your laboratory save time and money. Imagine how easy life at the bench could be if all your data was stored in one app connected to every device! These solutions are becoming more and more common in all research labs, but when it comes to implementing a […]

July 7, 2016 - 1 minutemin - By Joachim Eeckhout

cormorant interleukin 8 bms immuno oncology

News and Trends 7 Jul 2016

BMS to acquire Swedish Immuno-Oncology Biotech for €460M

Bristol-Myers Squibb wants to strengthen its immuno-oncology even further. For this, it is acquiring Cormorant – a Biotech developing immunotherapies in a deal that could go up to €460M. Based at the Karolinska Institute Science Park in Stockholm (Sweden), Cormorant was a private Biotech focusing on cancer immunotherapies. Its main program was HuMax-IL8, which is currently in Phase […]

July 7, 2016 - 2 minutesmins - By Denise Neves Gameiro

News and Trends 7 Jul 2016

Engineered Microorganisms now able to directly produce Bioplastics for 3D-Printing

Carbios made a breakthrough in the production of PLA, a common bioplastic. The lactic acid used as molecular ‘building blocks’ were already bio-sourced, but now the plastic can be really produced from scratch with microorganisms. Bioplastics are one of the ways GreenTech is trying to save the world. Some success stories are Bio-On’s potato plastics […]

July 7, 2016 - 2 minutesmins - By Denise Neves Gameiro

multiple sclerosis zinbryta daclizumab biogen abbvie

News and Trends 6 Jul 2016

Newly Approved therapy reduces frequency of Multiple Sclerosis relapses by 54%

Biogen and AbbVie have been granted EU marketing authorization for Zinbryta (daclizumab), to treat adult patients with relapsing forms of multiple sclerosis. Relapse frequency per year was shown to be reduced by up to 45% against other treatments, and 54% against placebo. Biogen is trying to emphasise the need for choice of treatments for MS, as the […]

July 6, 2016 - 3 minutesmins - By Dani Bancroft

News and Trends 6 Jul 2016

This company ensures quality DNA suitable for Clinical applications from demanding Human body fluid Samples

For today’s sensitive clinical genetic testing applications, making a fast and affordable isolation of high-quality nucleic acids from whole blood or plasma samples is a key bottleneck. But hey, here is a solution! Nucleic acid quantity and purity is crucial to perform the best NGS (Next Generation Sequencing), as well as other downstream processes like chip-based assays. […]

July 6, 2016 - 4 minutesmins - By Jerome Topsent

tigenix takeda stem cell therapy crohns fistula

News and Trends 6 Jul 2016

Takeda snatches up Belgian Cell therapy for Crohn’s Disease

TiGenix is licensing the rights for its cell therapy which is under EMA review and is meant to treat a serious complication of Crohn’s disease. This worldwide exclusivity deal (with exception to the US) could be worth up to €380M. Back in 2009, Leuven-based TiGenix was the first to launch at cell-based product (ChondroCellect) on the European market. […]

July 6, 2016 - 3 minutesmins - By Denise Neves Gameiro

Knowledge hub

Categories

Catalonia: A biotech hub going from strength to strength, with Barcelona at its core

Top biotech deals of February 2025

Approaches

Therapeutic areas

Grab your free report on 3D organoids and explore their future potential

These 7 biotechs are shaping the next generation of endometriosis care

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us

Catalonia: A biotech hub going from strength to strength, with Barcelona at its core

Top biotech deals of February 2025

Grab your free report on 3D organoids and explore their future potential

These 7 biotechs are shaping the next generation of endometriosis care

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Nanobody Phase II Results for Arthritis: Good but not good enough?

How to build a Successful Biotech company in Europe with Joern Aldag

Bio-printing Clothes and Darwin’s book ‘On the Origin of Species’ with Bacteria

Copenhagen-based Pcovery is looking to fight invasive Fungal Infections

French Startup raised €4M for Gene Therapy to fix specific Types of Blindness

Sanofi and the US Army team up for a Zika Vaccine, but why isn’t everyone else?

How to Integrate a Digital Notebook into your Lab?

BMS to acquire Swedish Immuno-Oncology Biotech for €460M

Engineered Microorganisms now able to directly produce Bioplastics for 3D-Printing

Newly Approved therapy reduces frequency of Multiple Sclerosis relapses by 54%

This company ensures quality DNA suitable for Clinical applications from demanding Human body fluid Samples

Takeda snatches up Belgian Cell therapy for Crohn’s Disease

Subscribe to our newsletter to get the latest biotech news!

Catalonia: A biotech hub going from strength to strength, with Barcelona at its core

Top biotech deals of February 2025

Grab your free report on 3D organoids and explore their future potential

These 7 biotechs are shaping the next generation of endometriosis care

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Catalonia: A biotech hub going from strength to strength, with Barcelona at its core

Top biotech deals of February 2025

Grab your free report on 3D organoids and explore their future potential

These 7 biotechs are shaping the next generation of endometriosis care

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Subscribe to our newsletter

Get the latest biotech news directly to your inbox!

Newsletter Signup - Footer

Subscribe to our newsletter to get the latest biotech news!